Director Shareholding

GlaxoSmithKline PLC
15 July 2002

                              Director's Interests


I give below details of changes in interests in the Ordinary Share ADRs of
GlaxoSmithKline plc (each ADR represents two Ordinary Shares) in respect of the
under-mentioned director arising from the purchase of Ordinary Share ADRs on 5
July 2002 from the reinvestment of the dividend paid to Ordinary Share ADR
holders on the 5 July 2002 through the US Global BuyDirect Plan administered by
The Bank of New York:-


Mr D F McHenry    Beneficial interest in .2240 of an Ordinary Share ADR 
                  purchased at a price of $41.3894 per ADR.

                  Mr McHenry and the Company were advised of this
                  information on 12 July 2002.


S M Bicknell

Company Secretary

15 July 2002


                      This information is provided by RNS
            The company news service from the London Stock Exchange